; Aarkstore.com || T-Cell Leukemia – Pipeline Review, H2 2012 || Market Research
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

Aarkstore.com || T-Cell Leukemia – Pipeline Review, H2 2012 || Market Research

VIEWS: 1 PAGES: 5

  • pg 1
									Aarkstore.com announces, The Latest market research report is available in
its vast collection:

T-Cell Leukemia – Pipeline Review, H2 2012


http://www.aarkstore.com/reports/T-Cell-Leukemia-Pipeline-Review-H2-
2012-220662.html


You can also request for sample page of above mention reports on
sample@aarkstore.com




Summary

Global Markets Direct’s, T-Cell Leukemia - Pipeline Review, H2 2012, provides an
overview of the T-Cell Leukemia therapeutic pipeline. This report provides
information on the therapeutic development for T-Cell Leukemia, complete with
latest updates, and special features on late-stage and discontinued projects. It also
reviews key players involved in the therapeutic development for T-Cell Leukemia. T-
Cell Leukemia - Pipeline Review, H2 2012 is built using data and information
sourced from Global Markets Direct’s proprietary databases, Company/University
websites, SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put together by
Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for T-Cell Leukemia.
- A review of the T-Cell Leukemia products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
- Coverage of the T-Cell Leukemia pipeline on the basis of route of administration
and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description,
mechanism of action and research & development progress.

Table of contents:

List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
T-Cell Leukemia Overview 9
Therapeutics Development 10
An Overview of Pipeline Products for T-Cell Leukemia 10
T-Cell Leukemia Therapeutics under Development by Companies 12
T-Cell Leukemia Therapeutics under Investigation by Universities/Institutes 13
Mid Clinical Stage Products 15
Comparative Analysis 15
Early Clinical Stage Products 16
Comparative Analysis 16
Pre-Clinical Stage Products 17
Comparative Analysis 17
T-Cell Leukemia Therapeutics – Products under Development by Companies 18
T-Cell Leukemia Therapeutics – Products under Investigation by
Universities/Institutes 19
Companies Involved in T-Cell Leukemia Therapeutics Development 20
Bristol-Myers Squibb Company 20
Kyowa Hakko Kirin Co., Ltd. 21
Merck & Co., Inc. 22
Novartis AG 23
Pfizer Inc. 24
Celgene Corporation 25
Mundipharma International Limited 26
Pharmacyclics, Inc. 27
T-Cell Leukemia – Therapeutics Assessment 28
Assessment by Monotherapy Products 28
Assessment by Combination Products 29
Assessment by Route of Administration 30
Assessment by Molecule Type 32
Drug Profiles 35
MK-4827 - Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
LBH589 - Drug Profile 36
Product Description 36
Mechanism of Action 36



List of Figures

List of Tables are also include.




For more related Reports Plz follow The link:

Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1




T-Cell Leukemia – Pipeline Review, H2 2012

Hypercalcemia – Pipeline Review, H2 2012

Diabetic Gastroparesis – Pipeline Review, H2 2012

Acute Lung Injury – Pipeline Review, H2 2012
Essential Thrombocythemia – Pipeline Review, H2 2012

Edema – Pipeline Review, H2 2012

Coronary Stenosis – Pipeline Review, H2 2012

Hypoglycemia – Pipeline Review, H2 2012

Nasopharyngitis (Common Cold) – Pipeline Review, H2 2012

AIDS Associated Dementia – Pipeline Review, H2 2012

Open-Angle Glaucoma – Pipeline Review, H2 2012




Search More Reports Related to This Category :


Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1




For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

								
To top